Tabs
Jennifer Popovic, DVM, MA; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA
Sarah Dutcher, PhD; Office of Research and Standards/Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Joshua Gagne, PharmD, ScD; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital, Boston
Michael Nguyen, MD; Sukhminder Sandhu, PhD, MPH, MS; Joel Weissfeld, MD, MPH; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Rima Izem, PhD; Yueqin Zhao, PhD; Office of Biostatistics, Center for Drug Evaluation and Research, FDA, Silver Spring, MD
Wenlei Jiang, PhD; Zhong (John) Wang, PhD; Office of Research and Standards/Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Patty Greene, PharmD; Aaron Niman, Simone Pinheiro, ScD, MSc; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD
Timothy Glavin; Adee Kennedy, MS, MPH; Andrew Petrone, MPH; Darren Toh, ScD; Anita Wagner, PharmD, MPH, DrPH; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA